Skip to main content
. 2010 Oct;24(10):588–592. doi: 10.1155/2010/891252

TABLE 2.

Demographic and laboratory features of the two groups of patients treated with mycophenolate mofetil before initiating therapy

Total Conventional therapy
P
Failure Intolerance
Age, years 50 (25–80) 46.3 (25–61) 55.7 (35–80) 0.12
Female, % 81 75 89 0.73
Weight, kg 79 (47–117) 82 (47–117) 75 (61–91) 0.92
Alkaline phosphatase, U/L (normal <140 U/L) 232 (82–1522) 156 (91–260) 346 (82–1522) 0.30
Aspartate aminotransferase, U/L (normal <35 U/L) 801 (64–3967) 880 (64–3967) 695 (95–3099) 0.41
Alanine aminotransferase (normal <40 U/L) 762 (72–3218) 746 (72–3218) 782 (94–1659) 0.79
Immunoglobulin G, g/L (normal range 7 g/L–16 g/L) 22.1 18.8 26.7 0.34
White blood cell count, ×109/L 7.7 (2.2–11.2) 7.6 (3.6–11.2) 7.8 (2.2–10.9) 0.90

Data presented as mean (range) unless indicated otherwise